Categories: Press Release

Europe Biomanufacturing Viral Detection and Quantification Market is Growing at a CAGR of 9.8% – BIS Research

The European market for biomanufacturing viral detection and quantification is rapidly expanding due to the increasing utilization of biopharmaceutical products. With ongoing technological advancements and a commitment to maintaining elevated standards, the market is poised for sustained growth in the sector. The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032.

Market Analysis: Trends, Data, and Growth Projections

As the demand for biologics continues to grow, ensuring the safety, effectiveness, and consistency of these products becomes progressively crucial. Robust quality control measures are imperative to adhere to regulations and safeguard the integrity of the products. One essential procedure in this regard is the assessment of viral contamination during the biomanufacturing process. Consequently, there is a notable upswing in demand for consumables and instruments in the European biomanufacturing viral detection and quantification market.

BIS Research, a leading market research firm, has released a report titled- Europe Biomanufacturing Viral Detection and Quantification Market, which discusses the challenges, growth factors, and future opportunities driving the remarkable growth of the Europe biomanufacturing viral detection and quantification market.

Key Players and Market Shares

Some major companies operating in the Europe biomanufacturing viral detection and quantification market are:

Merck KGaA
Sartorius AG
QIAGEN N.V.

The Europe biomanufacturing viral detection and quantification market is segmented into consumables, instruments, and services in terms of offering type. Technology segmentation includes PCR, ELISA, flow cytometry, plaque assay, and others. Applications are categorized into blood and blood products manufacturing, vaccines and therapeutics manufacturing, cellular and gene therapy products manufacturing, stem cell products manufacturing, and tissue and tissue products manufacturing. End users encompass life science companies, testing laboratories, and CROs and CDMOs. The market is further segmented by country, covering Germany, France, the U.K., Spain, Italy, and the rest of Europe.

Market Drivers, Challenges, and Opportunities

The Europe biomanufacturing viral detection and quantification market is driven by heightened demand due to increased use of biopharmaceuticals and technological advancements. However, challenges include the high cost of advanced equipment and a shortage of trained professionals in viral detection. Opportunities emerge with the growing need for precise viral contamination considerations in cell and gene therapy development. Navigating this landscape requires addressing cost constraints and investing in professional training, while capitalizing on the expanding opportunities presented by evolving biopharmaceuticals and advanced therapies.

Analyst Note

BIS principal analyst suggests: “The development of testing methods such as polymerase chain reaction (PCR) and real-time PCR (qPCR) allows for the rapid and precise detection of viral infections by allowing the measurement of viral nucleic acids with great accuracy and sensitivity. From the perspective of large-scale identification, the utilization of real-time PCR and genome sequencing methods is impractical due to the costly laboratory infrastructure and the need for highly skilled personnel for sample processing and analysis. Advanced and effective viral detection is being made possible by innovative nanophotonic biosensors and RADICA technologies.”

Cell and Gene Therapy Manufacturing QC Market

Cell and Gene Therapy Biomanufacturing Market

About BIS Research

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.